Allergan Doesn’t Oppose MDL For Biocell Breast Implants But Suggests New Jersey

(November 4, 2019, 1:45 PM EST) -- WASHINGTON, D.C. — Allergan Inc. on Nov. 1 told a federal judicial panel that it does not opposed centralization of 17 federal medical monitoring lawsuits involving Biocell textured breast implants but says the U.S. District Court for the District of New Jersey would be a better transferee court (In Re:  Allergan Biocell Breast Implant Litigation, MDL Docket No. 2921, JPMDL)....

Attached Documents

Related Sections